My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 188

    1.

    Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial.

    Weissman NJ, Panza JA, Tighe JF, Gwynne JT.

    Ann Intern Med. 2001 Feb 20;134(4):267-73.PMID: 11182836 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment.

    Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT.

    J Am Coll Cardiol. 1999 Dec;34(7):2088-95.PMID: 10588229 [PubMed - indexed for MEDLINE]Related articles

    3.

    An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.

    Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT.

    N Engl J Med. 1998 Sep 10;339(11):725-32.PMID: 9731088 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.

    Gardin JM, Weissman NJ, Leung C, Panza JA, Fernicola D, Davis KD, Constantine GD, Reid CL.

    JAMA. 2001 Oct 24-31;286(16):2011-4.PMID: 11667938 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.

    Mast ST, Jollis JG, Ryan T, Anstrom KJ, Crary JL.

    Ann Intern Med. 2001 Feb 20;134(4):261-6.PMID: 11182835 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.

    Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL.

    JAMA. 2000 Apr 5;283(13):1703-9.PMID: 10755496 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.

    Ryan DH, Bray GA, Helmcke F, Sander G, Volaufova J, Greenway F, Subramaniam P, Glancy DL.

    Obes Res. 1999 Jul;7(4):313-22.PMID: 10440587 [PubMed - indexed for MEDLINE]Related articles

    8.

    Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine.

    Kancherla MK, Salti HI, Mulderink TA, Parker M, Bonow RO, Mehlman DJ.

    Am J Cardiol. 1999 Dec 1;84(11):1335-8.PMID: 10614800 [PubMed - indexed for MEDLINE]Related articles

    9.

    Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.

    Wee CC, Phillips RS, Aurigemma G, Erban S, Kriegel G, Riley M, Douglas PS.

    Ann Intern Med. 1998 Dec 1;129(11):870-4. Erratum in: Ann Intern Med 2000 Jan 18;132(2):167. PMID: 9867728 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.

    Khan MA, Herzog CA, St Peter JV, Hartley GG, Madlon-Kay R, Dick CD, Asinger RW, Vessey JT.

    N Engl J Med. 1998 Sep 10;339(11):713-8.PMID: 9731086 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Dexfenfluramine and heart-valve regurgitation in Chinese patients with type 2 diabetes.

    Ko GT, Chan HC, Chow CC.

    Hong Kong Med J. 2003 Aug;9(4):243-6.PMID: 12904610 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prevalence and diagnostic value of precordial murmurs for valvular regurgitation in obese patients treated with dexfenfluramine.

    Roldan CA, Gill EA, Shively BK.

    Am J Cardiol. 2000 Sep 1;86(5):535-9.PMID: 11009272 [PubMed - indexed for MEDLINE]Related articles

    13.

    Low risk of significant echocardiographic valvulopathy in patients treated with anorectic drugs.

    Burger AJ, Charlamb MJ, Singh S, Notarianni M, Blackburn GL, Sherman HB.

    Int J Cardiol. 2001 Jul;79(2-3):159-65.PMID: 11461737 [PubMed - indexed for MEDLINE]Related articles

    14.

    Specificity of Doppler echocardiography for the assessment of changes in valvular regurgitation: comparison of side-by-side versus serial interpretation.

    Weissman NJ, Panza JA, Tighe JF Jr, Perras ST, Kushner H, Gottdiener JS.

    J Am Coll Cardiol. 2001 May;37(6):1614-21.PMID: 11345374 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine.

    Shively BK, Roldan CA, Gill EA, Najarian T, Loar SB.

    Circulation. 1999 Nov 23;100(21):2161-7.PMID: 10571975 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.

    Jick H, Vasilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE.

    N Engl J Med. 1998 Sep 10;339(11):719-24.PMID: 9731087 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Natural history of valvular regurgitation using side-by-side echocardiographic analysis in anorexigen-treated subjects.

    Klein AL, Griffin BP, Grimm RA, Rodriguez LL, Sallach JA, Morehead AJ.

    Am J Cardiol. 2005 Dec 15;96(12):1711-7. Epub 2005 Nov 2.PMID: 16360362 [PubMed - indexed for MEDLINE]Related articles

    18.

    Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine.

    Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR, Jensen MD.

    Mayo Clin Proc. 1999 Dec;74(12):1191-7.PMID: 10593346 [PubMed - indexed for MEDLINE]Related articles

    19.

    Operation for anorexigen-associated valvular heart disease.

    Caccitolo JA, Connolly HM, Rubenson DS, Orszulak TA, Schaff HV.

    J Thorac Cardiovasc Surg. 2001 Oct;122(4):656-64.PMID: 11581595 [PubMed - indexed for MEDLINE]Related articles

    20.

    Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study.

    Palmieri V, Arnett DK, Roman MJ, Liu JE, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Morgan D, de Simone G, Devereux RB.

    Am J Med. 2002 Jun 15;112(9):710-5.PMID: 12079711 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity